Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer
Clinical trial NCT00741260 · COMPLETED
Trial details
- NCT number
- NCT00741260
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-09
- Primary completion
- 2010-11-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.